Menu
Recruiting NCT06169592

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

— Observational Liver Cirrhosis Liver Transplant; Complications

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Liver transplantation.
Who it may be relevant to
Registry conditions: Liver Cirrhosis, Liver Transplant; Complications. Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Uzbekistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Verification of Prognostic Risk Factors of Thrombohemorrhagic Complications in Early Follow-up Period in Recipients After Living Related Liver Transplantation

Overview

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Interventions

  • Procedure Liver transplantation
    Related transplantation of the right lobe of the liver

Primary outcome measures

  • Thrombosis of vascular anastomosis [Time frame: 1 month]
Secondary outcome measures (1)
  • Hemorrhagic complications [Time frame: 1 month]

Eligibility criteria

Inclusion criteria

  • Age over 18 years and up to 70 years;
  • Signed informed consent for inclusion to the study;
  • End stage liver cirrhosis.

Exclusion criteria

  • Pregnancy;
  • Extrahepatic factors influencing systemic hemostasis;
  • Concomitant hematological diseases affecting the hemostatic system;
  • Severe concomitant disorders.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

Uzbekistan · 1 center
  • Republican specialized scientific and practical medical center of surgery named after acad — Tashkent

Identifiers

NCT: NCT06169592 · 05122023

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗